Van Broekhoven A (33 results)

Hardcover. Condition: Brand New. 192 pages. 6.00x0.50x9.00 inches. In Stock.

Original publisher's red cloth spine, gray boards, red dustjacket with white lettering spine and frontcover, 12mo: [60]pp., 6 page-large illustrations with glassine page, colophon. Untrimmed. Very fine copy. Printed in 200 numbered copies. This is nr. 20.

Condition: New.

Condition: New.

Condition: As New. Unread book in perfect condition.

Condition: New.

Condition: As New. Unread book in perfect condition.

Condition: New.

Condition: New.

Condition: New.

Condition: New. In English.

Condition: New. In English.

Condition: New.

Condition: As New. Unread book in perfect condition.

Condition: As New. Unread book in perfect condition.

Condition: New. Presents a selection of different approaches for the production of novel biotechnological compounds for biomedical applications. This book includes contributions linking genomics with bacterial resistance, antibiotics with improved production strategies, and optimised production approaches with chemical development programs. Editor(s): Broekhoven, Annie van; Shapiro, Fred R.; Anne, Jozef. Series: Focus on Biotechnology. Num Pages: 460 pages, biography. BIC Classification: MBG; MQW. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 235 x 155 x 25. Weight in Grams: 1820. . 2001. Hardback. . . . .…

Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - The present book entitled 'Novel Frontiers in the Production of Compounds for Biomedical Uses' can perhaps be placed in its best perspective by the Shakespearean character in The Tempest who exclaimed' What's past is prologue'. Indeed, this compilation of some of the outstanding presentations in the field of biomedicine made at th the 9 European Congress on Biotechnology (Brussels, Belgium, July 11-15, 1999) not only reflects the achievements of the recent past, but provides a privileged glimpse of the biotechnology that is emerging in the first decade of the new Millennium. It is becoming increasingly apparent that biotechnology is offering biomedicine novel approaches and solutions to develop a sorely needed new generation of biopharmaceuticals. This is all the more necessary because in recent years, new diseases have emerged with extraordinary lethality in all corners of the globe, while age-related chronic illnesses have filled the gap wherever biomedicine has made successful inroads. The rise of antibiotic resistance also poses major threats to public health. Thus, as disease patterns evolve, the rational development of new drugs is becoming urgent, not only for the clinical outcome of patients, but also in optimising the allocation of scarce health care resources through the use of cost-effective productions methods. It is in response to all these challenges that biotechnology offers new strategies that go beyond the more traditional approaches. By the mid-1990's, the number of recombinant products approved annually for therapeutic use reached double digits. With the advent of the genomics revolution.…

Gebunden. Condition: New.

Condition: New. pp. 460.

Condition: New. pp. 464.

Paperback. Condition: Brand New. 2001 edition. 464 pages. 9.25x6.10x1.05 inches. In Stock.

Condition: New. Presents a selection of different approaches for the production of novel biotechnological compounds for biomedical applications. This book includes contributions linking genomics with bacterial resistance, antibiotics with improved production strategies, and optimised production approaches with chemical development programs. Editor(s): Broekhoven, Annie van; Shapiro, Fred R.; Anne, Jozef. Series: Focus on Biotechnology. Num Pages: 460 pages, biography. BIC Classification: MBG; MQW. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 235 x 155 x 25. Weight in Grams: 1820. . 2001. Hardback. . . . . Books ship from the US and Ireland.…

Buch. Condition: Neu. Neuware - The present book entitled 'Novel Frontiers in the Production of Compounds for Biomedical Uses' can perhaps be placed in its best perspective by the Shakespearean character in The Tempest who exclaimed' What's past is prologue'. Indeed, this compilation of some of the outstanding presentations in the field of biomedicine made at th the 9 European Congress on Biotechnology (Brussels, Belgium, July 11-15, 1999) not only reflects the achievements of the recent past, but provides a privileged glimpse of the biotechnology that is emerging in the first decade of the new Millennium. It is becoming increasingly apparent that biotechnology is offering biomedicine novel approaches and solutions to develop a sorely needed new generation of biopharmaceuticals. This is all the more necessary because in recent years, new diseases have emerged with extraordinary lethality in all corners of the globe, while age-related chronic illnesses have filled the gap wherever biomedicine has made successful inroads. The rise of antibiotic resistance also poses major threats to public health. Thus, as disease patterns evolve, the rational development of new drugs is becoming urgent, not only for the clinical outcome of patients, but also in optimising the allocation of scarce health care resources through the use of cost-effective productions methods. It is in response to all these challenges that biotechnology offers new strategies that go beyond the more traditional approaches. By the mid-1990's, the number of recombinant products approved annually for therapeutic use reached double digits. With the advent of the genomics revolution.…

Zwolle, Waanders/ Rijksdienst voor de Monumentenzorg. 2001. 29,5 x 22 cm. In linnen gebonden met stofomslag. Hardcover. Met vele foto's. 246 pag. NIEUW EXEMPLAAR nog verpakt in folie. [Architecture / Dutch [Nederlandse Architectuur] Topography / Dutch [Nederlandse Topografie] ].

Taschenbuch. Condition: Neu. Sharing Knowledge and Cultural Heritage: First Nations of the Americas | Laura van Broekhoven (u. a.) | Taschenbuch | Mededelingen van het Rijksmuseum voor Volkenkunde 39 | Englisch | 2010 | Sidestone Press | EAN 9789088900662 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu Print on Demand.…

Taschenbuch. Condition: Neu. Creating Authenticity | Alexander Geurds (u. a.) | Taschenbuch | Mededelingen van het Rijksmuseum voor Volkenkunde 42 | Kartoniert / Broschiert | Englisch | 2013 | Sidestone Press | EAN 9789088902055 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu Print on Demand.…

Condition: new. Questo è un articolo print on demand.

Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The present book entitled 'Novel Frontiers in the Production of Compounds for Biomedical Uses' can perhaps be placed in its best perspective by the Shakespearean character in The Tempest who exclaimed' What's past is prologue'. Indeed, this compilation of some of the outstanding presentations in the field of biomedicine made at th the 9 European Congress on Biotechnology (Brussels, Belgium, July 11-15, 1999) not only reflects the achievements of the recent past, but provides a privileged glimpse of the biotechnology that is emerging in the first decade of the new Millennium. It is becoming increasingly apparent that biotechnology is offering biomedicine novel approaches and solutions to develop a sorely needed new generation of biopharmaceuticals. This is all the more necessary because in recent years, new diseases have emerged with extraordinary lethality in all corners of the globe, while age-related chronic illnesses have filled the gap wherever biomedicine has made successful inroads. The rise of antibiotic resistance also poses major threats to public health. Thus, as disease patterns evolve, the rational development of new drugs is becoming urgent, not only for the clinical outcome of patients, but also in optimising the allocation of scarce health care resources through the use of cost-effective productions methods. It is in response to all these challenges that biotechnology offers new strategies that go beyond the more traditional approaches. By the mid-1990's, the number of recombinant products approved annually for therapeutic use reached double digits. With the advent of the genomics revolution. 464 pp. Englisch. …

Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The present book entitled ¿Novel Frontiers in the Production of Compounds for Biomedical Uses¿ can perhaps be placed in its best perspective by the Shakespearean character in The Tempest who exclaimed' What¿s past is prologue¿. Indeed, this compilation of some of the outstanding presentations in the field of biomedicine made at th the 9 European Congress on Biotechnology (Brussels, Belgium, July 11-15, 1999) not only reflects the achievements of the recent past, but provides a privileged glimpse of the biotechnology that is emerging in the first decade of the new Millennium. It is becoming increasingly apparent that biotechnology is offering biomedicine novel approaches and solutions to develop a sorely needed new generation of biopharmaceuticals. This is all the more necessary because in recent years, new diseases have emerged with extraordinary lethality in all corners of the globe, while age-related chronic illnesses have filled the gap wherever biomedicine has made successful inroads. The rise of antibiotic resistance also poses major threats to public health. Thus, as disease patterns evolve, the rational development of new drugs is becoming urgent, not only for the clinical outcome of patients, but also in optimising the allocation of scarce health care resources through the use of cost-effective productions methods. It is in response to all these challenges that biotechnology offers new strategies that go beyond the more traditional approaches. By the mid-1990¿s, the number of recombinant products approved annually for therapeutic use reached double digits. With the advent of the genomics revolution.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 464 pp. Englisch. …

Condition: New. Print on Demand pp. 460 49:B&W 6.14 x 9.21 in or 234 x 156 mm (Royal 8vo) Perfect Bound on White w/Gloss Lam.